Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jing Diamond Biomedical is a Taiwan-based medical aesthetics company specializing in the development and commercialization of minimally invasive medical devices and high-end skincare products. The company is best known for its proprietary MIRA-Line lifting threads, which are the first absorbable threads developed and manufactured in Taiwan to receive regulatory approval for facial rejuvenation. Jing Diamond operates a vertically integrated business model that encompasses research and development, GMP-certified manufacturing, and a network of aesthetic clinics. Their product portfolio primarily targets facial skin laxity and anti-aging through collagen stimulation and advanced topical formulations. Listed on the Taiwan Emerging Stock Market, the company is actively expanding its footprint across Asia and international markets. Their commitment to innovation is supported by collaborations with clinical experts and academic institutions in the field of dermatology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jing Diamond Biomedical.